Rezolute

Rezolute

  • Founded: 2010
  • Location: Redwood City, CA
  • Employee range: 11 - 50
  • Clinical stage: Clin3
  • Therapy area: Congenital hyperinsulinism
  • Drug types: RAR, END, GEN, OPH
  • Lead product: RZ358
  • Product link: https://www.rezolutebio.com/disease-focus/pipeline/
  • Funding: $122M stock Apr 2022; $55M stock Oct 2021; $20M stock Jul 2019


rezolutebio.com

linkedin.com

job board


Short description:

Biologics

Drug notes:

RZ402 Clin2 diabetic macular edema

Long description:

Contact us to add description: recruit@workinbiotech.com

Jobs:


© 2024 Work In Biotech LLC
Personal data

Terms of Service

Privacy Policy

Contact: recruit@workinbiotech.com